Yuling Yuan

Dr. Yuling Yuan

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
YTYuandan Tan
Yuandan Tan
YLYujie Liu
Yujie Liu
AKAmi Koga
Ami Koga
YYYuling Yuan
Yuling Yuan
HYHaohan Yu
Haohan Yu
JLjingmin liu
jingmin liu
Objective: To compare the efficacy of exercise modalities for simultaneously improving homeostasis model assessment for insulin resistance (HOMA-IR) and total testosterone in women with polycystic ovary syndrome (PCOS). Methods: We conducted a Bayesian network meta-analysis of 19 randomized controlled trials (n = 808) to evaluate six exercise interventions: yoga, moderate-intensity continuous training (MICT), high-intensity interval training (HIIT), resistance training (RT), combined aerobic-resistance training (CT), and control (CG). Primary outcomes were changes in HOMA-IR and total testosterone, with interventions ranked via surface under the cumulative ranking curve (SUCRA). Results: For HOMA-IR reduction, yoga (SUCRA = 90.73%; SMD = −0.73, 95% CrI: −1.3 to −0.086) and HIIT (SUCRA = 74.12%; SMD = −0.47, 95% CrI: −0.75 to −0.15) demonstrated superior efficacy versus MICT (SUCRA = 50.56%) and CT (SUCRA = 42.29%), while RT was the least effective (SUCRA = 32.53%). For testosterone lowering, yoga was ranked the highest again (SUCRA = 92.46%; SMD = −0.85, 95% CrI: −1.7 to −0.12), followed by MICT (SUCRA = 75.72%; SMD = −0.56, 95% CrI: −0.97 to −0.25) and HIIT (SUCRA = 61.12%; SMD = −0.42, CrI: −0.88 to −0.12). CT and RT showed non-significant effects for both outcomes (p > 0.05). Conclusions: Yoga is the optimal intervention for dual-pathway improvement in PCOS. HIIT and MICT provide outcome-specific benefits (metabolic vs. endocrine), whereas CT and RT necessitate protocol refinement. Systematic review registration: This systematic review and network meta-analysis study was registered in PROSPERO (CRD420251011979).

28 July 2026 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
YWYoudi Wei
Youdi Wei
YLYujie Liu
Yujie Liu
YYYuling Yuan
Yuling Yuan
Background: The rising prevalence of overweight and obesity has become a critical global health issue. Previous researches have demonstrated that mindfulness-based interventions can improve both BMI and weight-related behaviour. Digital delivery improves accessibility, but evidence for BMI and eating outcomes remains inconclusive. This systematic review and meta-analysis synthesizes the available evidence on the impact of such interventions on BMI and weight-related behaviour in adults. Methods: A systematic literature search was performed across PubMed, Web of Science Core Collection, and Scopus. Eligible studies evaluated the effects of mindfulness-based digital health interventions on adult BMI and weight-related behaviour (e.g., binge eating, emotional eating). Data extraction and risk of bias assessment were carried out independently, and meta-analyses were conducted on pre-post intervention outcomes. Results: A total of 10 studies were included involving 902 participants. Mindfulness-based digital health interventions may significantly improve binge eating [SMD = −0.59, 95%CI: (−1.07, −0.10)], and emotional eating [SMD = −0.23, 95%CI: (−0.45, −0.02)]. No significant effects were observed for uncontrolled eating [SMD = −0.17, 95%CI: (−0.38, 0.05)] or cognitive restraint [SMD = −0.04, 95%CI: (−0.66, 0.59)]. The impact on BMI remained non-significant [MD = −0.44, 95%CI: (−1.70, 0.82)]. Conclusion: Mindfulness-based digital health interventions effectively alleviated emotional eating and binge eating; however, the improvement in BMI was not significant. These findings suggest that future research should focus on continually refining the details of the intervention protocol to enhance study robustness. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251125050 , PROSPERO, identifier number CRD420251125050.